IL-6 and stroke recurrence in ischemic stroke

This study aimed to evaluate the predictive value of IL-6 for stroke recurrence in acute ischemic stroke. Patients who were admitted within 48 h of onset were included. At 3-month, stroke recurrence was assessed. IL-6 levels were measured in serum samples taken upon admission. Out of the 305 patients, 47 (15.4%) experienced a stroke recurrence. The risk of stroke recurrence increased by 8% (OR: 1.08; 95% CI: 1.04-1.11;